These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 23064094)

  • 1. [Combined or coadministred Measles, Mumps, Rubella and Varicella Vaccines? That is the question!].
    Laudati F; Zaratti L; Franco E
    Ig Sanita Pubbl; 2012; 68(2):313-21. PubMed ID: 23064094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined vaccine against measles, mumps, rubella, and varicella.
    Brunell PA; Novelli VM; Lipton SV; Pollock B
    Pediatrics; 1988 Jun; 81(6):779-84. PubMed ID: 2835743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles, mumps, rubella vaccine and allergy to egg.
    Lang S
    Am Fam Physician; 1998 Sep; 58(4):863-4. PubMed ID: 9767722
    [No Abstract]   [Full Text] [Related]  

  • 4. National Advisory Committee on Immunization (NACI). Interim advisory on measles revaccination of persons with acquired immunodeficiency syndrome (AIDS).
    Can Commun Dis Rep; 1996 Jul; 22(14):116-7. PubMed ID: 8754936
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety and immunogenicity of a combined live attenuated measles, mumps, rubella, and varicella vaccine (MMR(II)V) in healthy children.
    Watson BM; Laufer DS; Kuter BJ; Staehle B; White CJ; Starr SE
    J Infect Dis; 1996 Mar; 173(3):731-4. PubMed ID: 8627041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varicella vaccination in a primary care pediatric practice.
    Meine EK; Bailey SR; Drucker RP; Clements DA; Walter E
    Arch Pediatr Adolesc Med; 1998 Jun; 152(6):608-9. PubMed ID: 9641722
    [No Abstract]   [Full Text] [Related]  

  • 7. MMR vaccine coverage at 24 months stabilises in the UK.
    Commun Dis Rep CDR Wkly; 1999 Mar; 9(13):113, 116. PubMed ID: 10230112
    [No Abstract]   [Full Text] [Related]  

  • 8. Measles, mumps, and rubella: recommendations for children/adolescents.
    Nurse Pract; 1996 Oct; 21(10):88, 91-2, 94. PubMed ID: 8895194
    [No Abstract]   [Full Text] [Related]  

  • 9. Combination measles, mumps, rubella and varicella vaccine.
    Arbeter AM; Baker L; Starr SE; Levine BL; Books E; Plotkin SA
    Pediatrics; 1986 Oct; 78(4 Pt 2):742-7. PubMed ID: 3763291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MMR vaccine is not linked to Crohn's disease or autism.
    Commun Dis Rep CDR Wkly; 1998 Mar; 8(13):113. PubMed ID: 9592960
    [No Abstract]   [Full Text] [Related]  

  • 11. MMR vaccination and autism.
    Wakefield AJ
    Lancet; 1999 Sep; 354(9182):949-50. PubMed ID: 10489978
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region].
    Salvadori P
    Ann Ig; 1998; 10(1):19-24. PubMed ID: 9616974
    [No Abstract]   [Full Text] [Related]  

  • 13. [Infant with febrile convulsions/incidental convulsions in the history: how does one proceed with diphtheria-pertussis-tetanus (DPT) and mumps-measles-rubella (MMR) preventive vaccination?].
    Wiersbitzky S; Bruns R; Burtzlaff C
    Kinderarztl Prax; 1993 Nov; 61(9):339-40. PubMed ID: 8114462
    [No Abstract]   [Full Text] [Related]  

  • 14. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures.
    Klein NP; Fireman B; Yih WK; Lewis E; Kulldorff M; Ray P; Baxter R; Hambidge S; Nordin J; Naleway A; Belongia EA; Lieu T; Baggs J; Weintraub E;
    Pediatrics; 2010 Jul; 126(1):e1-8. PubMed ID: 20587679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of age.
    Gatchalian S; Cordero-Yap L; Lu-Fong M; Soriano R; Ludan A; Chitour K; Bock HL
    Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):511-7. PubMed ID: 10774661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified varicella-like syndrome in children previously vaccinated with live attenuated measles, mumps, rubella and varicella vaccine.
    Walter EB; Simmons SS; Bland CL; Clements DA
    Pediatr Infect Dis J; 1997 Jun; 16(6):626-7. PubMed ID: 9194116
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunization of healthy children with measles-mumps-rubella trivalent vaccine simultaneously given with varicella vaccine].
    Takayama N; Kidokoro M; Suzuki K; Morita M
    Kansenshogaku Zasshi; 1992 Jun; 66(6):776-80. PubMed ID: 1331262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revaccination against measles and rubella.
    Cutts FT
    BMJ; 1996 Mar; 312(7031):589-90. PubMed ID: 8595319
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC; Burgess MA; O'Brien ED
    Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.